STUDY DOCUMENTS
Patient information note and consent for collection of biological samples Information note given to the patient presenting the data collection for the constitution of a database for research and evaluation of care. Patient consent form for the conservation and eventual use of biological samples for research purposes.
STATUS PROGRESS
Etat d'avancement UroCCR - novembre 2021
SCIENTIFIC PRODUCTION
BIBLIOGRAPHY RELATED TO THE UROCCR STUDY
Fourrier-Réglat A., Noize P., Rouyer M., Balestra A., Bignon E., Moore N., Bernhard J-C., Ravaud A. INTERET DES BASES CLINICO-BIOLOGIQUES EN PHARMACO-EPIDEMIOLOGIE : LA BASE UROCCR POUR LA SURVEILLANCE DES EFFETS INDESIRABLES DES THERAPIES CIBLEES UTILISEES DANS LE CANCER DU REIN METASTATIQUE (ETUDE CARLA REIN). Journées du Cancéropôle Grand Sud-Ouest, octobre 2013.
Bernhard JC, Patard JJ. LE PROJET UROCCR : DE LA BASE DE DONNEES MULTICENTRIQUE PLURIDISCIPLINAIRE AU RESEAU NATIONAL MEDICO-SCIENTIFIQUE. Correspondances in Onco-Urology. 2012, vol. 3, no. 2, pp. 72-74.
Bernhard JC et al. PRESENTATION D’UN MODELE DE BASE DE DONNEES MULTIDISCIPLINAIRE EN RESEAU SUR LE CANCER DU REIN. Prog Urol., November 2009 (Vol 19, number 10).
BIBLIOGRAPHY ON PROJECTS BENEFITED FROM THE SCIENTIFIC CONTRIBUTION OF THE UROCCR NETWORK (CASE INCLUSIONS)
Zine-Eddine Khene, Alessandro Larcher, Jean-Christophe Bernhard, Nicolas Doumerc, Idir Ouzaid, Umberto Capitanio, Francois-Xavier Nouhaud, Romain Boissier, Nathalie Rioux-Leclercq, Alexandre De La Taille, Philippe Barthelemy, Francesco Montorsi, Morgan Roupret, Pierre Bigot, Karim Bensalah EXTERNAL VALIDATION OF THE ASSURE MODEL FOR PREDICTING ONCOLOGICAL OUTCOMES AFTER RESECTION OF HIGH-RISK RENAL CELL CARCINOMA (RESCUE STUDY: UROCCR 88)
C Alegorides, P Bigot, J Hardwigsen, V Vidal, A Riberi, M Andre, B Gondran-Tellier, M Baboudjian, F Michel, G Karsenty, E Lechevallier, J C Bernhard, R Boissier IMMEDIATE PREOPERATIVE RENAL ARTERY EMBOLIZATION IN THE RESECTION OF COMPLEX RENAL TUMORS (UROCCR-48 REINBOL STUDY).
Adil Mellouki, Imad Bentellis, Arnoult Morrone, Nicolas Doumerc, Jean-Baptiste Beauval, Morgane Roupret, François-Xavier Nouhaud, Cedric Lebacle, Jean-Alexandre Long, Daniel Chevallier, Brannwell Tibi, Aysha Shaikh, L Imbert de la Phalecque, Pierre Pilot, Xavier Tillou, Jean-Christophe Bernhard, Matthieu Durand, Youness Ahallal EVALUATION OF ONCOLOGICAL OUTCOMES OF ROBOTIC PARTIAL NEPHRECTOMY ACCORDING TO THE TYPE OF HILAR CONTROL APPROACH (ON-CLAMP VS OFF-CLAMP), A MULTICENTRIC STYDU OF THE FRENCH NETWORK OF RESEARCH ON KIDNEY CANCER- UROCCR 58
Grégoire Cazalas , Eva Jambon, Alexis Coussy, Yann Le Bras, François Petitpierre, Jean Christophe Berhnard, Nicolas Grenier, Clément Marcelin LOCAL RECURRENCE AND OTHER ONCOLOGIC OUTCOMES AFTER PERCUTANEOUS IMAGE-GUIDED TUMOR ABLATIONS ON STAGET1B RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
Marie Brassier, Zine-Eddine Khene, Jean-Christophe Bernhard, Van Thi Dang, Idir Ouzaid, François Xavier Nouhaud, Jonathan Olivier, Cosmina Nedelcu, Nicolas Grenier, Luc Beuzit, Nicolas Doumerc Karim, Bensalah, Pierre Bigot, Members of the French Commitee of Urologic Oncology PERCUTANEOUS ABLATION VERSUS SURGICAL RESECTION FOR LOCAL RECURRENCE FOLLOWING PARTIAL NEPHRECTOMY FOR RENAL CELL CANCER : A PROPENSITY SCORE ANALYSIS (REPART STUDY-UROCCR 71)
Michael Baboudjian, Bastien Gondran Tellier, Zineddine Khene, Pierre Bigot, Arnaud Mejean, Hervé lang, Cedric Lebacle, Nicolas Doumerc, Franck Bruyere, Francois Xavier Nouhaud, Idir Ouzaid, Karim Bensalah, Jean Christophe Bernhard, Romain Boissier PREDICTIVE FACTORS OF RECURRENCE AFTER SURGERY IN PATIENTS WITH NON METASTATIC RENAL CELL CARCINOMA WITH VENOUS TUMOR THROMBUS (UROCCR 56 STUDY)
Damien Ambrosetti, Michael Coutts, Charlotte Paoli, Matthieu Durand, Delphine Borchiellini, Christopher Montemagno, Olivia Rastoin, Arnaud Borderie, Renaud Grepin, Nathalie Rioux-Leclercq, Jean-Christophe Bernhard, Gilles Pagès, Maeva Dufies CANCER ASSOCIATED FIBROBLASTS IN RENAL CELL CARCINOMA: IMPLICATION IN PROGNOSIS AND RESISTANCE TO ANTIANGIOGENIC THERAPY.
Alexandre Ingels1, Sophie Duc, Karim Bensalah, Pierre Bigot, Philippe Paparel, Jean Baptiste Beauval, Laurent Salomon, Alexandre De La Taille, Hervé Lang, François Xavier Nouhaud, José Batista Da Costa, Charles Dariane, Hervé Baumert, Morgan Roupret, Thibaut Waeckel, Cédric Lebacle, Jean Alexandre Long, François Henon, Jean Jacques Patard, Nicolas Doumerc, Arnaud Mejean, Marie Neige Videau & Jean Christophe Bernhard POSTOPERATIVE OUTCOMES OF ELDERLY PATIENTS UNDERGOING PARTIAL NEPHRECTOMY
Aurélien Morini, Tom Drossart, Marc-Olivier Timsit, Mathilde Sibony, Viorel Vasiliu, Anne-Paule Gimenez-Roqueplo, Judith Favier, Cécile Badoual1, Arnaud Mejean, Nelly Burnichon and Virginie Verkarre LOW-GRADE ONCOCYTIC RENAL TUMOR (LOT): MUTATIONS IN MTOR PATHWAY GENES AND LOW EXPRESSION OF FOXI1
Clément Michiels, Zine‑Eddine Khene, Thomas Prudhomme, Astrid Boulenger de Hauteclocque, François Cornelis, Mélanie Percot, Hélène Simeon, Laure Dupitout, Henri Bensadoun, Grégoire Capon, Eric Alezra, Vincent Estrade, Franck Bladou, Grégoire Robert, Jean‑Marie Ferriere, Nicolas Grenier, Nicolas Doumerc, Karim Bensalah, Jean‑Christophe Bernhard 3D‑IMAGE GUIDED ROBOTIC‑ASSISTED PARTIAL NEPHRECTOMY: A MULTI‑INSTITUTIONAL PROPENSITY SCORE‑MATCHED ANALYSIS (UROCCR STUDY 51).
Lindsay S. Cooley, Justine Rudewicz, Wilfried Souleyreau, Andrea Emanuelli, Arturo Alvarez Arena, Kim Clarke, Francesco Falciani, Maeva Dufies, Diether Lambrechts, Elodie Modave, Domitille Chalopin Fillot, Raphael Pineau, Damien Ambrosetti, Jean Christophe Bernhard, Alain Ravaud, Sylvie Négrier, Jean Marc Ferrero, Gilles Pagès, Sebastien Benzekry, Macha Nikolski and Andreas Bikfalvi EXPERIMENTAL AND COMPUTATIONAL MODELING FOR SIGNATURE AND BIOMARKER DISCOVERY OF RENAL CELL CARCINOMA PROGRESSION
C. Michiels, E. Jambon, J. Sarrazin, A. Boulenger de Hauteclocque, S. Ricard, N. Grenier, M. Faessel, F. Bos, J.C. Bernard REVUE COMPREHENSIVE DE L'APPORT DE L'IMPRESSION 3D EN MEDECINE : MISE EN PERSPECTIVE DES DIFFERENTES APPLICATIONS EN UROLOGIE.
Maeva Dufies, Annelies Verbiest, Lindsay S. Cooley, Papa Diogop Ndiaye, Xingkang He, Nicolas Nottet, Wilfried Souleyreau, Anais Hagege, Stephanie Torrino, Julien Parola, Sandy Giuliano, Delphine Borchiellini, Renaud Schiappa, Baharia Mograbi, Jessica Zucman-Rossi, Karim Bensalah, Alain Ravaud, Patrick Auberger, Andréas Bikfalvi, Emmanuel Chamorey, Nathalie Rioux-Leclercq, Nathalie M. Mazure, Benoit Beuselinck, Yihai Cao, Jean Christophe Bernhard, Damien Ambrosetti & Gilles Pagès PLK1, UPREGULATED BY HIF-2, MEDIATES METASTASIS AND DRUG RESISTANCE OF CLEAR CELL RENAL CELL CARCINOMA.
Bernhard JC, Robert G, Ricard S, Michiels C, Capon G, Boulenger de Hautecloque A, Bensadoun H, Gay J, Rogier J, Tauzin-Fin P, Gross-Goupil M, Benard A, Nouette K, Roullet S, Ferrière JM DAY-CASE ROBOTIC-ASSISTED PARTIAL NEPHRECTOMY : FEASIBILITY AND PRELIMINARY RESULTS OF A PERSPECTIVE EVALUATION (UROCCR-25 AMBU-REIN STUDY)
Nam-Son Vuong, Jean-Marie Ferriere, Clément Michiels, Laura Calen, Lorenso Tesi, Grégoire Capon, Henri Bensadoun, Eric Alezra, Vincent Estrade, Grégoire Robert, Franck Bladou, Jean-Christophe Bernhard ROBOT-ASSISTED VERSUS OPEN SURGERY FOR RADICAL NEPHRECTOMY WITH LEVEL 1-2 VENA CAVA TUMOR THROMBECTOMY : A FRENCH MONOCENTER EXPERIENCE (UROCCR STUDY #73).
Nicolas Epaillard, Audrey Simonaggio, Reza Elaidi, Fouzia Azzouz, Elena Braychenko, Constance Thibault, Cheng-Ming Sun, Marco Moreira, Stéphane Oudard, Yann-Alexandre Vano BIONIKK: A PHASE 2 BIOMARKER DRIVEN TRIAL WITH NIVOLUMAB AND IPILIMUMAB OR VEGFR TYROSINE KINASE INHIBITOR (TKI) IN NAÏVE METASTATIC KIDNEY CANCER.
C.Michiels, A.Boulenger deHauteclocque, J.Sarrazin, F.Cornelis, S.Ricard, M.Faessel,N.Grenier, F.Bos, J.C Bernhard UTILISATION DE L'IMPRESSION 3D AVANT NEPHRECTOMIE PARTIELLE POUR TUMEUR DU REIN.
C Aubert, C Rolley, M Mauny, J Heuveline, E Silve, M Humeau, V Le Corre, S Lebdai, E Brassart, T Culty, N Baize, M C Rousselet, C Nedelcu, C Aubé, A Bouvier, P Bigot IMPACT OF PARTIAL NEPHRECTOMY IN A HYBRID OPERATING ROOM ON THE ACTIVITY OF KIDNEY CANCER SURGERY.
Alegorides C, Bigot P, Hardwigsen J, Vidal V, Riberi A, Andre M, Gondran-Tellier B, Baboudjian M, Michel F, Karsenty G, Lechevallier E, Bernhard JC, Boissier R INTERET DE L’EMBOLISATION ARTERIELLE RENALE AVANT CHIRURGIE POUR TUMEURS RENALES AVEC ENVAHISSEMENT VEINEUX.
Borojeni S, Borojeni A, Panayotopoulos P, Bouvier A, Aubé C, Azzouzi AR, Bigot P STUDY OF RENAL AND KIDNEY TUMOR VASCULARIZATION USING DATA FROM PREOPERATIVE THREE-DIMENSIONAL ARTERIOGRAPHY PRIOR TO PARTIAL NEPHRECTOMY. Eur Urol Focus. 2020 Jan 15;6(1):112-121
Germain Bréhier, Antoine Bouvier, Louis Besnier, Serge Willoteaux, Cosmina Nedelcu, Thibaut Culty, Christophe Aubé & Pierre Bigot RENAL FUNCTION AFTER PARTIAL NEPHRECTOMY FOLLOWING INTRA‑ARTERIAL EMBOLIZATION OF RENAL TUMORS.
C. Aubera, C. Rolley, M. Mauny, J. Heuveline ,E. Silve, M. Humeau, V. Le Corre, S. Lebdai ,E. Brassart, T. Culty, N. Baize, M.C. Rousselet, C. Nedelcu, C. Aubé, A. Bouvier, P. Bigot ÉVALUATION DE L’UTILISATION DE LA SALLE HYBRIDE SUR L’ACTIVITE DE CHIRURGIE EN CANCEROLOGIE.
Ouzaid I., Bernhard JC., Bigot P., Nouhaud FX., Long JA., Boissier R., Gimel P., Bodin T., Hetet JF., Méjean A., Albiges L., Bensalah K. TENDANCES DANS LA PRATIQUE DE LA CHIRURGIE RENALE POUR LE CANCER EN FRANCE, APRES L’INTRODUCTION DE LA CHIRURGIE ROBO-ASSISTEE : DONNEES DU REGISTRE NATIONAL DES SYSTEMES DE SANTE.
Boissier R, Bernhard JC, Bigot P, Dariane C, Lang H, Doumerc N, Beauval JB Lebacle C, Bruyere F, Nouhaud F, Tillou X, Long JA, Durand M, Charles T, Chevreau C, Oudard S, Albiges L, Ravaud A,Mejean A, Bensalah K INTERET DU TRAITEMENT ADJUVANT PAR ANTIANGIOGENIQUE VERSUS SURVEILLANCE APRES NEPHRECTOMIE POUR TUMEUR RENALE M0 AVEC THROMBUS DE LA VEINE RENALE OU DE LA VEINE CAVE (ETUDE UROCCR-56). Prog Urol. 2019 Nov: 29(13): 646
J. Beauval, A. Méjean, N. Doumerc, M. Roupret, P. Paparel, A. Villers, F. Bruyere, C. Lebacle, F. Nouhaud, A. De la Taille, J. Rizk, H. Lang, M. Durand, C. Dariane, T. Charles, R. Boissier, J.A. Long, K. Bensalah, J. Bernard RESULTATS DE LA NEPHRECTOMIE PARTIELLE ROBOT-ASSISTEE CHEZ LES PATIENTS OBESES AVEC IMC >30 KG/M2 (ETUDE UROCCR-43 : ROBESE).
Khene ZE, Peyronnet B, Bernhard JC, Kocher NJ, Vaessen C, Doumerc N, Pradere B, Seisen T, Beauval JB, Verhoest G, Roumiguié M, De la Taille A, Bruyere F, Roupret M, Mejean A, Mathieu R, Shariat S, Raman JD, Bensalah K; members of the French Committee of Urologic Oncology (CCAFU) A PREOPERATIVE NOMOGRAM TO PREDICT MAJOR COMPLICATIONS AFTER ROBOT ASSISTED PARTIAL NEPHRECTOMY (UROCCR-57 STUDY). Urol Oncol. 2019 Sep;37(9):577.e1-577.e7
Kammerer-Jacquet SF, Brunot A, Lefort M, Bayat S, Peyronnet B, Verhoest G, Mathieu R, Lespagnol A, Mosser J, Laguerre B, Ravaud A, Bernhard JC, Dupuis F, Yacoub M, Belaud-Rotureau MA, Bensalah K, Rioux-Leclercq N METASTATIC CLEAR-CELL RENAL CELL CARCINOMA WITH A LONG-TERM RESPONSE TO SUNITINIB: A DISTINCT PHENOTYPE INDEPENDENTLY ASSOCIATED WITH LOW PD-L1 EXPRESSION. Clin Genitourin Cancer. 2019 Jun;17(3):169-176.e1
Michiels C., Jambon E., Sarrazin J., Faessel M., Latxague C., Boulenger De Hauteclocque A., Capon G., Bensadoun H., Robert G., Ferrière J-M., Bos F., Grenier N., Bernhard J-C. ABSTRACT ANATOMICAL ACCURACY OF 3D-PRINTED PATIENT-SPECIFIC KIDNEY MODELS USED FOR ROBOTASSISTED- PARTIAL NEPHRECTOMY PRE-OPERATIVE PLANNING (UROCCR STUDY N° 39 : 3D-PRINT).
Fontenil A, Bigot P, Bernhard JC, Beauval JB, Soulié M, Charles T, Larre S, Salomon L, Azzouzi R, Méjean A, Bensalah K; Cancerology Committee of the French Association of Urology (CCAFU) WHO IS DYING AFTER NEPHRECTOMY FOR CANCER? STUDY OF RISK FACTORS AND CAUSES OF DEATH AFTER ANALYZING MORBIDITY AND MORTALITY REVIEWS (UROCCR-33 STUDY). Prog Urol. 2019 Apr;29(5):282-287
Duc S., Bensalah K., Bigot P., Paparel P., Beauval J-B., Salomon L., De La Taille A., Bessede T., Lang H., Nouhaud F.X., Baumert H., Roupret M., Long J.A., Villers A., Patard J-J., Soulie M., Mejean A., Videau M-N., Bernhard J-C. POSTOPERATIVE OUTCOMES OF ELDERLY PATIENTS UNDERGOING PARTIAL NEPHRECTOMY: A MULTICENTRIC-STUDY OF THE FRENCH RESEARCH NETWORK ON KIDNEY CANCER UROCCR.
C.Michiels, J.Sarrazin, M.Faessel, C.Latxague, A.Boulenger de Hauteclocque, G.Capon, H.Bensadoun, G.Robert, J.-M.Ferrière, F.Bos, J.C.Bernhard APPORT DE L’IMPRESSION 3D A LACHIRURGIE RENALE MINI-INVASIVE : POURL’INFORMATION PREOPERATOIRE SPECIFIQUE— PATIENT ET POUR L’ENSEIGNEMENT DELA LECTURE DU SCANNER—(UROCCR STUDYNO 39—3DPRINT).
C. Michiels, J.C. Bernhard, J.B. Beauval, N. Doumerc, M. Roupret, C. Vaessen, C. Dariane, V. Flamand, J.-A. Long, P. Paparel, H. Baumert, F. Bruyere, H. Lang, L. Salomon, B. Guilloneau, A. Descazeaud, T. Lebret, M. Arnaud, J. Patard, K. Bensalah ROPAN : OBSERVATOIRE NATIONAL SUR LA NEPHRECTOMIE PARTIELLE ROBOTISEE.
Nouhaud FX, Bernhard JC, Bigot P, Khene ZE, Audenet F, Lang H, Bergerat S, Fraisse G, Grenier N, Cornelis F, Nedelcu C, Béjar S, Fromont-Hankard G, Allory Y, Lindner V, Verkarre V, Daniel L, Yacoub M, Correas JM, Méjean A, Rioux-Leclercq N, Bensalah K CONTEMPORARY ASSESSMENT OF THE CORRELATION BETWEEN BOSNIAK CLASSIFICATION AND HISTOLOGICAL CHARACTERISTICS OF SURGICALLY REMOVED ATYPICAL RENAL CYSTS (UROCCR-12 STUDY). World J Urol. 2018 Oct;36(10):1643-1649
Rouffilange J, Gobet A, Capon G, Comat V, Lagabrielle S, Guillaume A, Robert G, Bensadoun H, Ferrière JM, Bernhard JC PARTIAL NEPHRECTOMY FOR RENAL MASSES >7CM: MORBIDITY, ONCOLOGICAL AND FUNCTIONAL OUTCOMES (UROCCR-7 STUDY). Prog Urol. 2018 Oct;28(12):588-595
Reix B, Bernhard JC, Patard JJ, Bigot P, Villers A, Suer E, Vuong NS, Verhoest G, Alimi Q, Beauval JB, Benoit T, Nouhaud FX, Lenormand C, Hamidi N, Cai J, Eto M, Larre S, El Bakhri A, Ploussard G, Hung A, Koutlidis N, Schneider A, Carrouget J, Droupy S, Marchal S, Doerfler A, Seddik S, Matsugasumi T, Orsoni X, Descazeaud A, Pfister C, Bensalah K, Soulie M, Gill I, Flamand V; Kidney Cancer group of the CCAFU OVERALL SURVIVAL AND ONCOLOGICAL OUTCOMES AFTER PARTIAL NEPHRECTOMY AND RADICAL NEPHRECTOMY FOR CT2A RENAL TUMORS: A COLLABORATIVE INTERNATIONAL STUDY FROM THE FRENCH KIDNEY CANCER RESEARCH NETWORK UROCCR. Prog Urol. 2018 Mar;28(3):146-155
Solène-Florence Kammerer-Jacquet, Angelique Brunot, Karim Bensalah, Boris Campillo-Gimenez, Mathilde Lefort, Sahar Bayat, Alain Ravaud, Frantz Dupuis, Mokrane Yacoub, Gregory Verhoest, Benoit Peyronnet, Romain Mathieu, Alexandra Lespagnol, Jean Mosser, Julien Edeline, Brigitte Laguerre, Jean-Christophe Bernhard, Nathalie Rioux-Leclercq. HILAR FAT INFILTRATION: A NEW PROGNOSTIC FACTOR IN METASTATIC CLEAR CELL RENAL CELL CARCINOMA WITH FIRST-LINE SUNITINIB TREATMENT.
Dufies M, Giuliano S, Ambrosetti D, Claren A, Ndiaye PD, Mastri M, Moghrabi W, Cooley LS, Ettaiche M, Chamorey E, Parola J, Vial V, Lupu-Plesu M, Bernhard JC, Ravaud A, Borchiellini D, Ferrero JM, Bikfalvi A, Ebos JM, Khabar KS, Grépin R, Pagès G SUNITINIB STIMULATES EXPRESSION OF VEGFC BY TUMOR CELLS AND PROMOTES LYMPHANGIOGENESIS IN CLEAR CELL RENAL CELL CARCINOMAS. Cancer Res. 2017 Mar 1;77(5):1212-1226
Cornelis F, Ambrosetti D, Rocher L, Derchi LE, Renard B, Puech P, Claudon M, Rouvière O, Ferlicot S, Roy C, Yacoub M, Grenier N, Bernhard JC CT AND MR IMAGING FEATURES OF MUCINOUS TUBULAR AND SPINDLE CELL CARCINOMA OF THE KIDNEYS. A MULTI-INSTITUTIONAL REVIEW. Eur Radiol. 2017 Mar;27(3):1087-1095
Galmiche C, Bernhard JC, Yacoub M, Ravaud A, Grenier N, Cornelis F IS MULTIPARAMETRIC MRI USEFUL FOR DIFFERENTIATING ONCOCYTOMAS FROM CHROMOPHOBE RENAL CELL CARCINOMAS ? AJR Am J Roentgenol. 2017 Feb;208(2):343-350
Bigot P, Bernhard JC, Flamand V, Gill I, Verhoest G, Beauval JB, Nouhaud FX, Suer E, Ploussard G, Hetet JF, Rigaud J, Baco E, Larré S, Sebe P, Koutlidis N, Descazeaud A, Eto M, Doerfler A, Roupret M, Vuong NS, Reix B, Matsugasumi T, Bakri AE, Albiges L, Soulié M, Patard JJ, Méjean A, Bensalah K; members of the Kidney Cancer group of the CCAFU LOCALIZED CHROMOPHOBE CARCINOMAS TREATED BY NEPHRON-SPARING SURGERY HAVE EXCELLENT ONCOLOGIC OUTCOMES. Urol Oncol. 2017 Jan;35(1):35.e15-35.e19
Grassano Y., Cornelis F, Grenier N., Michiels C., Capon G., Bensadoun H., Pasticier G., Robert G., Ferriere J-M., Bernhard J-C MINIMALLY INVASIVE CONSERVATIVE TREATMENT OF LOCALIZED RENAL TUMORS: A SINGLE CENTER EXPERIENCE ON PERCUTANEOUS ABLATIONS AND ROBOT-ASSISTED PARTIAL NEPHRECTOMY.
Long JA, Bernhard JC, Bigot P, Lanchon C, Paparel P, Rioux-Leclercq N, Albiges L, Bodin T, Nouhaud FX, Boissier R, Gimel P, Méjean A, Masson-Lecomte A, Grenier N, Cornelis F, Grassano Y, Comat V, Le Clerc QC, Rigaud J, Salomon L, Descotes JL, Sengel C, Roupret M, Verhoest G, Ouzaid I, Arnoux V, Bensalah K; French association of Urology Cancerology Comitee (CCAFU) PARTIAL NEPHRECTOMY VERSUS ABLATIVE THERAPY FOR THE TREATMENT OF RENAL TUMORS IN AN IMPERATIVE SETTING. World J Urol. 2017 Apr;35(4):649-656
R. Boissier, S. Chkir, P. Bigot, S. Chelly, C. Dariane, Z. Khene, F. Nouhaud, A. Giwerc, J. Bernard, C. Allenet, P. Gimel, J. Long, P. Paparel, I. Ouzaid, T. Bodin, L. Albiges, N. Rioux-leclercq, K. Bensalah, A. Mejean SURVIE A LONG TERME DES TUMEURS KYSTIQUES DU REIN–ENQUETE DU CCA-AFU.
Bigot P, Bernhard JC, Gill IS, Vuong NS, Verhoest G, Flamand V, Reix B, Suer E, Gökce I, Beauval JB, Nouhaud FX, Eto M, Baco E, Matsugasumi T, Chowaniec Y, Rigaud J, Lenormand C, Pfister C, Hetet JF, Ploussard G, Roupret M, Léon P, Bakri AE, Larré S, Tillou X, Doerfler A, Descazeaud A, Koutlidis N, Schneider A, Sebe P, Ingels A, Azzouzi AR, Soulié M, Méjean A, Bensalah K, Patard JJ; members of the Kidney Cancer group of the CCAFU THE SUBCLASSIFICATION OF PAPILLARY RENAL CELL CARCINOMA DOES NOT AFFECT ONCOLOGICAL OUTCOMES AFTER NEPHRON SPARING SURGERY. World J Urol. 2016 Mar;34(3):347-52
Pierquet G, Zongo D, Robert G, Pasticier G, Maurice-Tison S, Bensadoun H, Ballanger P, Rouget B, Ferriere JM, Bernhard JC PARTIAL NEPHRECTOMY ON SOLITARY KIDNEY: RENAL FUNCTION OUTCOME AND PREDICTIVE FACTORS OF IMPAIRMENT. Prog Urol. 2016 Jan;26(1):34-40
Malouf GG, Compérat E, Yao H, Mouawad R, Lindner V, Rioux-Leclercq N, Verkarre V, Leroy X, Dainese L, Classe M, Descotes JL, Barthelemy P, Yacoub M, Rouprêt M, Bernhard JC, Creighton CJ, Spano JP, Su X, Khayat D UNIQUE TRANSCRIPTOMIC PROFILE OF COLLECTING DUCT CARCINOMAS RELATIVE TO UPPER TRACT UROTHELIAL CARCINOMAS AND OTHER KIDNEY CARCINOMAS. Sci Rep. 2016 Aug 3;6:30988
Peyronnet B, Pradère B, De La Taille A, Bruyère F, Doumerc N, Droupy S, Vaessen C, Baumert H, Bernhard JC, Rouprêt M, Mejean A, Bensalah K POSTOPERATIVE DRAINAGE DOES NOT PREVENT COMPLICATIONS AFTER ROBOTIC PARTIAL NEPHRECTOMY. World J Urol. 2016 Jul;34(7):933-8
Verhoest G, Couapel JP, Oger E, Rioux-Leclercq N, Pignot G, Patard JJ, Bex A, Panayotopoulos P, Bigot P, Eret V, Hora M, Turna B, Lefevre M, Rigaud J, Tillou X, Doerfler A, Xylinas E, Soorojebally Y, Rouprêt M, Lagabrielle S, Bernhard JC, Long JA, Berger J, Ravier E, Paparel P, Salomon L, Rodriguez AR, Bensalah K SAFETY AND FEASIBILITY OF LAPAROSCOPIC NEPHRECTOMY FOR BIG TUMORS (≥ 10 CM): A RETROSPECTIVE MULTICENTRIC STUDY. Clin Genitourin Cancer. 2016 Aug;14(4):e335-40
Pierre Bigot, Jean-Christophe Bernhard, Vincent Flamand, Inderbir Gill, Grégory Verhoest, Jean Baptiste Beauval, François Xavier Nouhaud, Evren Suer, Guillaume Ploussard, Jean François Hetet, Jérôme Rigaud, Eduard Baco, Stéphane Larré, Philippe Sebe, Nicolas Koutlidis, Aurélien Descazeaud, Masatoshi Eto, Arnaud Doerfler, Morgan Roupret, Nam Son Vuong, Boris Reix, Toru Matsugasumi, Adnan El Bakri, Laurence Albiges, Michel Soulié, Jean-Jacques Patard, Arnaud Méjean, Karim Bensalah, members of the Kidney Cancer group of the CCAFU LOCALIZED CHROMOPHOBE CARCINOMAS TREATED BY NEPHRON-SPARING SURGERY HAVE EXCELLENT ONCOLOGIC OUTCOMES.
Bernhard JC, Isotani S, Matsugasumi T, Duddalwar V, Hung AJ, Suer E, Baco E, Satkunasivam R, Djaladat H, Metcalfe C, Hu B, Wong K, Park D, Nguyen M, Hwang D, Bazargani ST, de Castro Abreu AL, Aron M, Ukimura O, Gill IS PERSONALIZED 3D PRINTED MODEL OF KIDNEY AND TUMOR ANATOMY: A USEFUL TOOL FOR PATIENT EDUCATION. World J Urol. 2016 Mar;34(3):337-45
Peyronnet B, Seisen T, Oger E, Vaessen C, Grassano Y, Benoit T, Carrouget J, Pradère B, Khene Z, Giwerc A, Mathieu R, Beauval JB, Nouhaud FX, Bigot P, Doumerc N, Bernhard JC, Mejean A, Patard JJ, Shariat S, Roupret M, Bensalah K; French Comittee of Urologic Oncology (CCAFU) COMPARISON OF 1800 ROBOTIC AND OPEN PARTIAL NEPHRECTOMIES FOR RENAL TUMORS. Ann Surg Oncol. 2016 Dec;23(13):4277-4283
Cornelis F, Tricaud E, Lasserre AS, Petitpierre F, Bernhard JC, Le Bras Y, Yacoub M, Bouzgarrou M, Ravaud A, Grenier N MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING FOR THE DIFFERENTIATION OF LOW AND HIGH GRADE CLEAR CELL RENAL CARCINOMA. Eur Radiol. 2015 Jan;25(1):24-31
Bigot P, Bernhard J, Verhoest G, Flammand V, Gill I, Vuong N, Reix B, Suer E, Gökce I, Beauval J, Nouhaud F, Eto M, Baco E, Matsugasumi T, Chowaniec Y, Rigaud J, Lenormand C, Pfister C, Hetet J, Ploussard G, Roupret M, Léon P, El Bakri A, Larré S, Tillou X, Ingels A, Doerfler A LE SOUS-TYPE HISTOLOGIQUE DES CARCINOMES TUBULO-PAPILLAIRES NE MODIFIE PAS LES RESULTATS ONCOLOGIQUES APRES NEPHRECTOMIE PARTIELLE. Prog Urol. 2015 Nov;25(13):799
Anne Sacré, Philippe Barthélémy, Clement Korenbaum, Mickael Burgy,Pascal Wolter, Herlinde Dumez, Evelyne Lerut, Tine Loyson, Steven Joniau,Raymond Oyen, Philip R. Debruyne, Patrick Schöffski & Benoit Beuselinck PROGNOSTIC FACTORS IN SECOND-LINE TARGETED THERAPY FOR METASTATIC CLEAR-CELL RENAL CELL CARCINOMA AFTER PROGRESSION ON AN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR.
Bernhard JC, Patard J, Bigot P, Suer E, Vuong N, Verhoest G, Alimi Q, Flamand V, Reix B, Beauval J, Benoit T, Nouhaud F, Lenormand C, Hamidi N, Eto M, Larre S, El Bakri A, Baco E, Ploussard G, Koutlidis N, Schneider A, Roupret M, Leon P, Carrouget J, Droupy S, Marchal S CANCER DU REIN CLINIQUEMENT LOCALISE : QUELS SONT LES FACTEURS PREDICTIFS DU RISQUE D'UPSTAGING PATHOLOGIQUE PT3A PAR INVASION DE LA GRAISSE ? Prog Urol. 2015 Nov;25(13):800
Bernhard JC, Bigot P, Pignot G, Baumert H, Zini L, Lang H, Crepel M, Monod P, Salomon L, Bellec L, Roupret M, Schneider M, Xylinas E, Paparel P, Bruyere F, Berger J, Ansieau JP, Gimel P, Salome F, Castagnola C, Pfister C, Legraverend JM, Timsit MO, Le Pellec L, Auberget JL, Rolland E, Mallet R, Mejean A, Patard JJ THE ACCURACY OF RENAL TUMOR BIOPSY: ANALYSIS FROM A NATIONAL PROSPECTIVE STUDY. World J Urol. 2015 Aug;33(8):1205-11
Bernhard JC, Payan A, Bensadoun H, Cornelis F, Pierquet G, Pasticier G, Robert G, Capon G, Ravaud A, Ferriere JM ARE WE READY FOR DAY-CASE PARTIAL NEPHRECTOMY?
Bigot P, Bernhard J, Gill I, Vuong N, Verhoest G, Flammand V, Reix B, Suer E, Gökce I, Beauval J, Nouhaud F, Eto M, Baco E, Matsugasumi T, Chowaniec Y, Rigaud J, Lenormand C, Pfister C, Hetet J, Ploussard G, Roupret M, Léon P, El Bakri A, Larré S, Tillou X, Doerfler A, Descazeaud A LES RESULTATS DE LA NEPHRECTOMIE PARTIELLE POUR LES CARCINOMES CHROMOPHOBES DU REIN SONT EXCELLENTS. ÉTUDE RETROSPECTIVE MULTICENTRIQUE A PARTIR DE 234 CAS. Prog Urol. 2015 Nov;25(13):800
Verhoest G, Patard JJ, Oger E, Rioux-Leclercq N, Peyronnet B, Bessède T, Laguna P, Barwari K, Rigaud J, Roupret M, Coffin G, Bernhard JC, Long JA, Zisman A, Berger J, Paparel P, Maurin C, Lechevallier E, Bertini R, Ouzaid I, Salomon L, Bex A, Farfara R, Ljungberg B, Rodriguez AR, Bensalah K PREDICTIVE FACTORS OF CHRONIC KIDNEY DISEASE STAGE V AFTER PARTIAL NEPHRECTOMY IN A SOLITARY KIDNEY: A MULTI-INSTITUTIONAL STUDY. Urol Oncol. 2014 Jan;32(1):28.e21-6
Albiges L, Guegan J, Le Formal A, Verkarre V, Rioux-Leclercq N, Sibony M, Bernhard JC, Camparo P, Merabet Z, Molinie V, Allory Y, Orear C, Couve S, Gad S, Patard JJ, Escudier B. MET IS A POTENTIAL TARGET ACROSS ALL PAPILLARY RENAL CELL CARCINOMAS. RESULT FROM A LARGE MOLECULAR STUDY OF PRCC WITH CGHA AND MATCHING GENE EXPRESSION ARRAY. Clin Cancer Res. 2014 Mar 21.
Cornelis F, Tricaud E, Lasserre AS, Petitpierre F, Bernhard JC, Le Bras Y, Yacoub M, Bouzgarrou M, Ravaud A, Grenier N ROUTINELY PERFORMED MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING HELPS TO DIFFERENTIATE COMMON SUBTYPES OF RENAL TUMOURS. Eur Radiol. 2014 May;24(5):1068-80
Peyronnet B, Baumert H, Mathieu R, Masson-Lecomte A, Grassano Y, Roumiguié M, Massoud W, Abd El Fattah V, Bruyère F, Droupy S, De La Taille A, Doumerc N, Berhnard JC, Vaessen C, Rouprêt M, Bensalah K. EARLY UNCLAMPING TECHNIQUE DURING ROBOTICALLY-ASSISTED LAPAROSCOPIC PARTIAL NEPHRECTOMY CAN MINIMIZE WARM ISCHEMIA WITHOUT INCREASING MORBIDITY. BJU Int. 2014 Apr 2.
Pignot G, Bigot P, Bernhard JC, Bouliere F, Bessede T, Bensalah K, Salomon L, Mottet N, Bellec L, Soulié M, Ferrière JM, Pfister C, Drai J, Colombel M, Villers A, Rigaud J, Bouchot O, Montorsi F, Bertini R, Belldegrun AS, Pantuck AJ, Patard JJ NEPHRON-SPARING SURGERY IS SUPERIOR TO RADICAL NEPHRECTOMY IN PRESERVING RENAL FUNCTION BENEFIT EVEN WHEN EXPANDING INDICATIONS BEYOND THE TRADITIONAL 4-CM CUTOFF. Urol Oncol. 2014 Oct;32(7):1024-30
Bigot P, Hétet JF, Bernhard JC, Fardoun T, Audenet F, Xylinas E, Ploussard G, Pignot G, Bessede T, Ouzaid I, Robine E, Brureau L, Merigot de Treigny O, Maurin C, Long JA, Rouffilange J, Hoarau N, Lebdai S, Rouprêt M, Bastien L, Neuzillet Y, Mongiat-Artus P, Verhoest G, Zerbib M, Ravery V, Rigaud J, Bellec L, Baumert H, Chautard D, Bensalah K, Escudier B, Paparel P, Grenier N, Rioux-Leclercq N, Azzouzi AR, Soulié M, Patard JJ.Clin. NEPHRON SPARING SURGERY FOR RENAL TUMORS MEASURING MORE THAN 7 CM: MORBIDITY, FUNCTIONAL AND ONCOLOGICAL OUTCOMES. GenitoUrinary Canc. 2014 Feb;12(1):e19-27.
Lang H, Mouracade P, Gimel P, Bernhard JC, Pignot G, Zini L, Crepel M, Rigaud J, Salomon L, Bellec L, Vaessen C, Roupret M, Jung JL, Mourey E, Martin X, Bigot P, Bruyère F, Berger J, Ansieau JP, Salome F, Hubert J, Pfister C, Trifard F, Gigante M, Baumert H, Méjean A, Patard JJ NATIONAL PROSPECTIVE STUDY ON THE USE OF LOCAL HAEMOSTATIC AGENTS DURING PARTIAL NEPHRECTOMY. BJU Int. 2014 May;113(5b):E56-61
Rouffilange J., Donon L., Capon G., Vergnolles M., Renard O., Ferretti L., Robert G., Ballanger P., Ferrière J-M., Bernhard J-C. PARTIAL NEPHRECTOMY FOR RENAL TUMORS OF MORE THAN 7 CM: ONCOLOGICAL, MORBIDITY AND RENAL FUNCTION OUTCOMES. Eur Urol Suppl 2013 ;12 ;e96 EAU annual meeting – Milan (Italy) 2013. (CA)
Capon Grégoire, Donon Laurence, Soulet Fabienne, Deminière Colette, Merlio Jean-Philippe, Doussau Adélaïde, Jullien De Pommerol Marie, Drutel Guillaume, Ravaud Alain, Quemener Cathy, Robert Grégoire, Pasticier Gilles, Ballanger Philippe, Bikfalvi Andréas, Ferrière Jean-Marie, Bernhard Jean-Christophe. PREDICTIVE FACTORS OF IMPAIRED FROZEN KIDNEY TISSUE SAMPLES QUALITY IN THE SETTING OF ROUTINE SURGICAL ACTIVITY. The Journal of Urology, May 2013 (Vol. 189, Issue 4, Supplement, e247) AUA annual meeting – San Diego (CA – USA) 2013. (CA)
Fergelot P, Bernhard JC, Soulet F, Kilarski WW, Léon C, Courtois N, Deminière C, Herbert JM, Antczak P, Falciani F, Rioux-Leclercq N, Patard JJ, Ferrière JM, Ravaud A, Hagedorn M, Bikfalvi A THE EXPERIMENTAL RENAL CELL CARCINOMA MODEL IN THE CHICK EMBRYO. Angiogenesis. 2013 Jan;16(1):181-94
L.Donon, M.Yacoub, G.Robert, C.Deminière, G.Pasticier, J-M.Ferrière, P.Ballanger, J-C.Bernhard 763 RENAL CELL CANCER IN YOUNG ADULTS: PREVALENCE, CHARACTERISTICS, AND IMPACT OF XP11.2/TFE3 TRANSLOCATION CARCINOMA DIAGNOSIS.
Donon L., Yacoub M., Robert G., Deminière C., Pasticier G., Ferrière J-M., Ballanger P., Bernhard J-C. RENAL CELL CANCER IN YOUNG ADULTS: PREVALENCE, CHARACTERISTICS, AND IMPACT OF XP11.2/TFE3 TRANSLOCATION CARCINOMA DIAGNOSIS. Eur Urol Suppl 2013;12;e763 EAU annual meeting – Milan (Italy) 2013. (CA)
Pierre Bigot, Tarek Fardoun, Jean Christophe Bernhard, Evanguelos Xylinas, Julien Berger, Morgan Roupret, Jean-Baptiste Beauval, Samuel Lagabrielle, Souhil Lebdai, Myriam Ammi, Hervé Baumert, Bernard Escudier, Nicolas Grenier, Jean-François Hetet, Jean-Alexandre Long, Philippe Paparel, Nathalie Rioux-Leclercq, Michel Soulié, Abdel-Rahmène Azzouzi, Karim Bensalah, Jean-Jacques Patard. NEOADJUVANT TARGETED MOLECULAR THERAPIES IN PATIENTS UNDERGOING NEPHRECTOMY AND INFERIOR VENA CAVA THROMBECTOMY: IS IT USEFUL? World J Urol. 2014 Feb;32(1):109-14. Epub 2013 Apr 27.
Brassart E, Lebdai S, Berger J, Traore S, Bernhard JC, Fardoun T, Muller G, Patard JJ, Azzouzi AR, Bigot P. OVERALL MORTALITY AFTER RADICAL NEPHRECTOMY IN PATIENTS AGED OVER 80 YEARS WITH RENAL CANCER: A RETROSPECTIVE STUDY ON PREOPERATIVE PROGNOSTIC FACTORS. Int J Urol. 2012 Jul;19(7):626-32.
Berget J, Fardoun T, Brassart E, Capon G, Bigot P, Bernhard JC, Rigaud J, Patard JJ, Descazeaud A. DETAILED ANALYSIS OF MORBIDITY FOLLOWING NEPHRECTOMY FOR RENAL CELL CARCINOMA IN OCTOGENERIANS. J Urol. 2012 Sep;188(3):736-40.
Douard A, Pasticier G, Deminiere C, Wallerand H, Ferriere JM, Bernhard JC. KIDNEY PRIMITIVE ANGIOSARCOMA: ABOUT A CASE AND REVIEW OF LITERATURE. Prog Urol. 2012; 22:438-41.
Boulière F, Crepel M, Bigot P, Pignot G, Bessede T, de la Taille A, Salomon L, Tostain J, Bellec L, Soulié M, Rischmann P, Bernhard JC, Ferrière JM, Pfister C, Albouy B, Colombel M, Zini L, Villers A, Rigaud J, Bouchot O, Patard JJ NEPHRON-SPARING SURGERY IS SUPERIOR TO RADICAL NEPHRECTOMY IN PRESERVING RENAL FUNCTION OUTCOME IN TUMORS LARGER THAN 4 CM. Prog Urol. 2011 Nov;21(12):842-50
Bernhard J.C., Quemener C., Soulet F., Deminiere C., Pineau R., Donon L., Merlio J.P., Ravaud A., Wallerand H., Pasticier G., Patard J.J., Ferriere J.M., Bikfalvi A. LEVEL OF EXPRESSION AND PROGNOSTIC VALUE OF CXCL4, CXCL4L1 AND CXCR3B IN CLEAR CELL RENAL CELL CARCINOMA. J Urol. 2010 May;183(4):e83
Last update of the site: 02/12/2021
All rights reserved UroCCR © 2013-2019. Legal Notice